Churchill Management Corp Vertex Pharmaceuticals Inc Transaction History

Churchill Management Corp

$9.08 Billion
Q4 2024

A detailed history of Churchill Management Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Churchill Management Corp holds 45,457 shares of VRTX stock, worth $21.9 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

45,457

Previous 45,355 0.22%

Holding current value

$21.9 Million

Previous $21.1 Million 13.22%

% of portfolio

0.2%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$396.64 - $516.74 $40,457 - $52,707	102 Added 0.22%	45,457 $18.3 Million
Q3 2024 Oct 15, 2024	SELL	$460.0 - $505.78 $230,460 - $253,395	-501 Reduced 1.09%	45,355 $21.1 Million
Q2 2024 Jul 22, 2024	SELL	$392.81 - $485.53 $125,699 - $155,369	-320 Reduced 0.69%	45,856 $21.5 Million
Q1 2024 Apr 11, 2024	SELL	$407.69 - $446.08 $150,029 - $164,157	-368 Reduced 0.79%	46,176 $19.3 Million
Q4 2023 Jan 16, 2024	SELL	$343.0 - $410.68 $794,731 - $951,545	-2,317 Reduced 4.74%	46,544 $18.9 Million
Q3 2023 Oct 12, 2023	SELL	$338.18 - $362.46 $520,797 - $558,188	-1,540 Reduced 3.06%	48,861 $17 Million
Q2 2023 Jul 18, 2023	SELL	$314.42 - $351.91 $803,971 - $899,833	-2,557 Reduced 4.83%	50,401 $17.7 Million
Q1 2023 Apr 13, 2023	SELL	$283.23 - $323.1 $627,637 - $715,989	-2,216 Reduced 4.02%	52,958 $16.7 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $526,941 - $592,809	-1,844 Reduced 3.23%	55,174 $15.9 Million
Q4 2022 Jan 10, 2023	BUY	$285.76 - $321.48 $14 Million - $15.8 Million	49,040 Added 614.69%	57,018 $16.5 Million
Q3 2022 Oct 11, 2022	BUY	$273.83 - $305.53 $11,774 - $13,137	43 Added 0.54%	7,978 $2.31 Million
Q2 2022 Jul 08, 2022	BUY	$234.96 - $292.55 $9,868 - $12,287	42 Added 0.53%	7,935 $2.24 Million
Q1 2022 Apr 12, 2022	BUY	$221.42 - $260.97 $76,389 - $90,034	345 Added 4.57%	7,893 $2.06 Million
Q4 2021 Jan 11, 2022	BUY	$177.01 - $223.45 $1.34 Million - $1.69 Million	7,548 New	7,548 $1.66 Million
Q4 2020 Jan 13, 2021	SELL	$207.01 - $276.09 $2.05 Million - $2.73 Million	-9,905 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$255.65 - $303.1 $1.25 Million - $1.48 Million	4,890 Added 97.51%	9,905 $2.7 Million
Q2 2020 Jul 17, 2020	BUY	$225.48 - $295.8 $1.13 Million - $1.48 Million	5,015 New	5,015 $1.46 Million
Q1 2020 Apr 09, 2020	SELL	$199.77 - $247.81 $20.8 Million - $25.9 Million	-104,350 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$166.71 - $223.91 $17.4 Million - $23.4 Million	104,350 New	104,350 $22.8 Million
Q4 2018 Jan 15, 2019	SELL	$151.91 - $192.21 $24 Million - $30.4 Million	-158,165 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$167.73 - $192.74 $26.5 Million - $30.5 Million	158,165 New	158,165 $30.5 Million

Others Institutions Holding VRTX

# of Institutions

1,712

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.

Account

Churchill Management Corp Vertex Pharmaceuticals Inc Transaction History